Our results showed that PARP1 and DNMT1 interacted with the DUX4 promoter, suggesting that this interaction may potentially play a significant role in the demethylation and subsequent upregulation of DUX4 observed in patients with FSHD. The gene discussed is DNMT1; the disease is facioscapulohumeral muscular dystrophy.